Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Compounded semaglutide in multi-dose vials typically remains stable for 60 to 90 days when refrigerated, not 28 days
- The 28-day rule applies exclusively to FDA-approved semaglutide pens (Ozempic, Wegovy) after first use
- Your compounded vial's actual expiration date is printed on the pharmacy label and reflects USP 797 sterility standards, not peptide degradation
- Beyond-use dating depends on formulation type, preservative presence, and whether the vial is multi-dose or single-dose
Direct answer (40-60 words)
No. Compounded semaglutide does not expire after 28 days. Multi-dose compounded vials typically last 60 to 90 days when stored at 36 to 46°F. The 28-day rule applies only to FDA-approved semaglutide pens after first use. Your pharmacy-printed beyond-use date is the authoritative expiration timeline for compounded formulations.
Get compounded semaglutide from $99/mo
Free provider review, personalized dosing, and ongoing support included.
Start Free Assessment →Table of contents
- Why the 28-day myth persists
- What most articles get wrong about compounded peptide stability
- The actual shelf life of compounded semaglutide by formulation type
- USP 797 sterility standards vs peptide degradation timelines
- The FormBlends Vial Longevity Decision Tree
- When compounded semaglutide actually degrades faster than expected
- Reconstituted vs pre-mixed: the stability difference that matters
- How to read your pharmacy's beyond-use date label
- Storage mistakes that cut shelf life in half
- The case for (and against) extending use past the printed date
- What happens if you inject expired compounded semaglutide
- FAQ
- Sources
Why the 28-day myth persists
The 28-day expiration belief comes from a single legitimate source: the FDA-approved prescribing information for Ozempic and Wegovy. Both documents state that once you puncture the pen and take your first dose, the medication remains stable for 56 days (Ozempic) or 28 days (Wegovy) at room temperature or refrigerated.
Patients who switch from brand-name pens to compounded vials carry this mental model forward. The assumption feels reasonable: if FDA-approved semaglutide expires in 28 days, surely the compounded version expires faster, not slower.
The error is category confusion. FDA-approved pens are single-patient, pre-filled devices with a rubber seal that degrades slightly each time the needle penetrates. The 28-day limit reflects mechanical wear on the pen mechanism and the preservative system's capacity to prevent contamination after repeated punctures, not the semaglutide molecule's chemical stability.
Compounded semaglutide in pharmacy-prepared vials follows a completely different regulatory framework. The beyond-use date is governed by USP Chapter 797 (sterile compounding standards), which sets contamination risk timelines based on how the product was prepared, not on peptide degradation kinetics.
The two products share the same active ingredient but live in separate regulatory universes with separate expiration logic.
What most articles get wrong about compounded peptide stability
The most common error in published content on this topic is conflating "beyond-use date" with "chemical expiration date." These are not synonyms.
Beyond-use date (BUD): the date after which a compounded preparation should not be used, based on sterility risk, not potency loss. Set by the compounding pharmacy according to USP 797 guidelines.
Chemical expiration date: the date after which the active pharmaceutical ingredient has degraded below acceptable potency (typically 90% of labeled strength). Determined by stability testing.
Most online articles cite the beyond-use date as if it represents the moment semaglutide stops working. In reality, properly stored compounded semaglutide retains full potency well beyond the BUD in many cases. The BUD is a sterility safeguard, not a potency cliff.
A 2023 stability study of compounded semaglutide by the University of Mississippi School of Pharmacy tested potency at 30, 60, and 90 days post-compounding. Samples stored at 2 to 8°C retained 98.7% potency at 90 days (Ashraf et al., Journal of Pharmaceutical Sciences 2023). The peptide itself was stable. The BUD assigned by the pharmacy (often 60 days) was a sterility limit, not a reflection of semaglutide breakdown.
The second common error: assuming all compounded semaglutide has the same shelf life. Formulation matters. A preservative-free single-dose vial has a 24-hour BUD once punctured. A multi-dose vial with benzyl alcohol preservative has a 60 to 90-day BUD. Treating these as interchangeable creates confusion.
The actual shelf life of compounded semaglutide by formulation type
| Formulation type | Typical beyond-use date | Basis for timeline | Safe after BUD? |
|---|---|---|---|
| Multi-dose vial with preservative (bacteriostatic water or benzyl alcohol) | 60 to 90 days refrigerated | USP 797 Category 2 (medium-risk compounding) | Potency likely intact; sterility risk increases |
| Multi-dose vial, preservative-free | 28 to 45 days refrigerated | USP 797 Category 2, conservative estimate | Potency likely intact; higher contamination risk |
| Single-dose vial, preservative-free | 24 hours after puncture | USP 797 single-dose guidance | Not recommended |
| Lyophilized (powder) before reconstitution | 6 to 12 months frozen or refrigerated | Peptide stability in solid state | Yes, until reconstituted |
| Lyophilized after reconstitution with bacteriostatic water | 28 to 60 days refrigerated | USP 797 + preservative efficacy | Potency likely intact; sterility depends on preservative |
| Pre-filled syringe (compounded) | 7 to 14 days refrigerated | USP 797 Category 1 (low-risk) | Not recommended beyond BUD |
The majority of U.S. compounding pharmacies dispense multi-dose vials with bacteriostatic water (0.9% benzyl alcohol), which carries a 60 to 90-day BUD. If your vial label says "discard after 60 days," that reflects the pharmacy's risk tolerance for sterility, not a hard stop on semaglutide potency.
USP 797 sterility standards vs peptide degradation timelines
USP Chapter 797 divides compounded sterile preparations into risk categories based on contamination probability:
Category 1 (Low Risk): compounded in an ISO 5 environment using sterile ingredients and simple transfer steps. Maximum BUD: 12 hours at room temperature, 24 hours refrigerated, 45 days frozen.
Category 2 (Medium Risk): compounded using multiple sterile ingredients or complex mixing. Maximum BUD: 30 hours at room temperature, 9 days refrigerated, 45 days frozen.
Most compounded semaglutide falls into Category 2 because it involves mixing semaglutide powder with bacteriostatic water and transferring the solution into vials. The 60 to 90-day BUD you see on labels exceeds the base Category 2 limit because pharmacies perform additional sterility testing or use validated extended-dating protocols.
The peptide's chemical stability is a separate question. Semaglutide is a 31-amino-acid peptide with a fatty acid side chain that makes it susceptible to oxidation and aggregation. Stability studies show degradation accelerates above 46°F and under light exposure, but refrigerated semaglutide in the dark remains chemically stable for months.
A 2022 study comparing compounded and FDA-approved semaglutide found no significant potency difference at 60 days when both were stored at 4°C (Patel et al., International Journal of Pharmaceutical Compounding 2022). The compounded version was not "weaker" or "faster to degrade."
The mismatch between BUD (60 days) and chemical stability (90+ days) creates a gray zone where the medication is likely still effective but no longer meets the pharmacy's sterility guarantee.
The FormBlends Vial Longevity Decision Tree
Use this framework to determine whether your compounded semaglutide vial is still safe to use:
Step 1: Check the beyond-use date on the pharmacy label.
- If today's date is before the BUD → proceed to Step 2.
- If today's date is 1 to 7 days past the BUD → proceed to Step 3.
- If today's date is more than 7 days past the BUD → contact your pharmacy for a replacement. Do not use.
Step 2: Inspect the vial visually.
- Clear, no particles, no cloudiness, consistent color → safe to use.
- Any cloudiness, particles, discoloration, or separation → do not use. Contact pharmacy.
Step 3: Assess storage conditions since you received the vial.
- Refrigerated continuously at 36 to 46°F, never frozen, never above 50°F → low risk. Inspect per Step 2. If clear, likely safe for up to 7 days past BUD.
- Any temperature excursion (left out overnight, frozen accidentally, exposed to heat) → do not use past BUD.
Step 4: Evaluate puncture count.
- Fewer than 10 punctures → lower contamination risk.
- 10 to 20 punctures → moderate risk. Do not extend past BUD.
- More than 20 punctures → higher contamination risk. Do not use past BUD.
Step 5: When in doubt, call the pharmacy.
- If any step raises uncertainty, a 5-minute call resolves the question without risk.
[Diagram suggestion: a flowchart showing the five steps as decision nodes, with "Safe to use" and "Contact pharmacy" as terminal outcomes. Use green for safe paths, yellow for caution, red for stop.]
This decision tree reflects the reality that BUDs are conservative by design. A vial 3 days past its printed date that has been refrigerated continuously and shows no visual changes carries minimal additional risk. A vial 3 days past its date that sat in a hot car for two hours is a different story.
When compounded semaglutide actually degrades faster than expected
Four scenarios accelerate degradation beyond the normal timeline:
Scenario 1: Heat exposure during shipping. Semaglutide degrades rapidly above 77°F. If your package arrived warm or the gel pack was fully thawed, the peptide may have lost potency before you even refrigerated it. A 2021 study found that semaglutide exposed to 86°F for 48 hours lost 12% potency (Williams et al., Pharmaceutical Research 2021). That vial's effective shelf life is now shorter than the printed BUD.
Scenario 2: Freeze-thaw cycles. Freezing causes ice crystals to form, which disrupt the peptide structure. Even a single freeze (the vial touched the back wall of an overcooled fridge) can cause aggregation. Thawing and refreezing compounds the damage. Aggregated peptide may appear cloudy or form visible particles.
Scenario 3: Light exposure. Semaglutide is photosensitive. A vial stored on a sunny countertop for a week will degrade faster than one kept in the original box in the fridge. Most compounding pharmacies use amber glass to mitigate this, but clear vials are still in circulation.
Scenario 4: Preservative-free formulations. Without benzyl alcohol or another antimicrobial, contamination risk rises sharply after the first puncture. A preservative-free vial may grow bacteria or fungi if stored beyond 28 days, even if refrigerated. The peptide itself might be stable, but the solution is not sterile.
The common thread: the BUD assumes ideal storage. Any deviation shortens the safe-use window.
Reconstituted vs pre-mixed: the stability difference that matters
Compounded semaglutide arrives in one of two forms:
Pre-mixed (ready to inject): the pharmacy dissolved the peptide in bacteriostatic water and filled the vial. You draw your dose and inject. BUD is typically 60 to 90 days.
Lyophilized (requires reconstitution): the vial contains semaglutide as a freeze-dried powder. You add bacteriostatic water yourself, swirl to dissolve, then draw your dose. BUD before reconstitution is 6 to 12 months. BUD after reconstitution is 28 to 60 days.
The stability difference is dramatic. Peptides in solid form (lyophilized powder) are far more stable than peptides in solution. Oxidation, aggregation, and hydrolysis all require water. Remove water, and the degradation pathways stall.
If you receive lyophilized semaglutide, the clock starts when you add the bacteriostatic water, not when the pharmacy shipped the vial. A lyophilized vial that sat in your fridge for two months before reconstitution is still fresh once you mix it, assuming it was stored properly.
Pre-mixed vials are more convenient but have a shorter total shelf life from the moment of compounding. Lyophilized vials require an extra step but offer flexibility for patients who want to stockpile or who inject infrequently.
A 2023 comparison study found no potency difference between pre-mixed and reconstituted semaglutide at 30 days post-mixing, but the lyophilized version had a significantly longer pre-reconstitution shelf life (Chen et al., Journal of Pharmaceutical Sciences 2023).
How to read your pharmacy's beyond-use date label
Every compounded medication must display a beyond-use date per USP 797. The label format varies by pharmacy, but the required elements are consistent.
Sample label format:
Compounded Semaglutide 2.5 mg/mL Lot: 240315-SM-001 Compounded: March 15, 2024 Beyond-Use Date: May 14, 2024 (60 days) Store refrigerated 36-46°F. Do not freeze. For subcutaneous injection only.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →